[en] Brain function is compromised in myotonic dystrophy type 1 (DM1), but the underlying mechanisms are not fully understood. To gain insight into the cellular and molecular pathways primarily affected, we studied a mouse model of DM1 and brains of adult patients. We found pronounced RNA toxicity in the Bergmann glia of the cerebellum, in association with abnormal Purkinje cell firing and fine motor incoordination in DM1 mice. A global proteomics approach revealed downregulation of the GLT1 glutamate transporter in DM1 mice and human patients, which we found to be the result of MBNL1 inactivation. GLT1 downregulation in DM1 astrocytes increases glutamate neurotoxicity and is detrimental to neurons. Finally, we demonstrated that the upregulation of GLT1 corrected Purkinje cell firing and motor incoordination in DM1 mice. Our findings show that glial defects are critical in DM1 brain pathophysiology and open promising therapeutic perspectives through the modulation of glutamate levels.
Disciplines :
Neurology
Author, co-author :
Sicot, Geraldine
Servais, Laurent ; Université de Liège - ULiège > Département des sciences cliniques > Neuropédiatrie
Algalarrondo, V., Wahbi, K., Sebag, F., Gourdon, G., Beldjord, C., Azibi, K., Balse, E., Coulombe, A., Fischmeister, R., Eymard, B., et al. Abnormal sodium current properties contribute to cardiac electrical and contractile dysfunction in a mouse model of myotonic dystrophy type 1. Neuromuscul. Disord. 25 (2015), 308–320.
Angeard, N., Gargiulo, M., Jacquette, A., Radvanyi, H., Eymard, B., Héron, D., Cognitive profile in childhood myotonic dystrophy type 1: is there a global impairment?. Neuromuscul. Disord. 17 (2007), 451–458.
Angeard, N., Jacquette, A., Gargiulo, M., Radvanyi, H., Moutier, S., Eymard, B., Héron, D., A new window on neurocognitive dysfunction in the childhood form of myotonic dystrophy type 1 (DM1). Neuromuscul. Disord. 21 (2011), 468–476.
Antonini, G., Soscia, F., Giubilei, F., De Carolis, A., Gragnani, F., Morino, S., Ruberto, A., Tatarelli, R., Health-related quality of life in myotonic dystrophy type 1 and its relationship with cognitive and emotional functioning. J. Rehabil. Med. 38 (2006), 181–185.
Bachasson, D., Moraux, A., Ollivier, G., Decostre, V., Ledoux, I., Gidaro, T., Servais, L., Behin, A., Stojkovic, T., Hébert, L.J., et al. Relationship between muscle impairments, postural stability, and gait parameters assessed with lower-trunk accelerometry in myotonic dystrophy type 1. Neuromuscul. Disord. 26 (2016), 428–435.
Batra, R., Charizanis, K., Manchanda, M., Mohan, A., Li, M., Finn, D.J., Goodwin, M., Zhang, C., Sobczak, K., Thornton, C.A., Swanson, M.S., Loss of MBNL leads to disruption of developmentally regulated alternative polyadenylation in RNA-mediated disease. Mol. Cell 56 (2014), 311–322.
Bearzatto, B., Servais, L., Cheron, G., Schiffmann, S.N., Age dependence of strain determinant on mice motor coordination. Brain Res. 1039 (2005), 37–42.
Bearzatto, B., Servais, L., Roussel, C., Gall, D., Baba-Aïssa, F., Schurmans, S., de Kerchove d'Exaerde, A., Cheron, G., Schiffmann, S.N., Targeted calretinin expression in granule cells of calretinin-null mice restores normal cerebellar functions. FASEB J. 20 (2006), 380–382.
Bellamy, T.C., Interactions between Purkinje neurones and Bergmann glia. Cerebellum 5 (2006), 116–126.
Brook, J.D., McCurrach, M.E., Harley, H.G., Buckler, A.J., Church, D., Aburatani, H., Hunter, K., Stanton, V.P., Thirion, J.P., Hudson, T., et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 68 (1992), 799–808.
Caillet-Boudin, M.L., Fernandez-Gomez, F.J., Tran, H., Dhaenens, C.M., Buee, L., Sergeant, N., Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy. Front. Mol. Neurosci., 6, 2014, 57.
Caliandro, P., Silvestri, G., Padua, L., Bianchi, M.L., Simbolotti, C., Russo, G., Masciullo, M., Rossini, P.M., fNIRS evaluation during a phonemic verbal task reveals prefrontal hypometabolism in patients affected by myotonic dystrophy type 1. Clin. Neurophysiol. 124 (2013), 2269–2276.
Charizanis, K., Lee, K.Y., Batra, R., Goodwin, M., Zhang, C., Yuan, Y., Shiue, L., Cline, M., Scotti, M.M., Xia, G., et al. Muscleblind-like 2-mediated alternative splicing in the developing brain and dysregulation in myotonic dystrophy. Neuron 75 (2012), 437–450.
Cheron, G., Gall, D., Servais, L., Dan, B., Maex, R., Schiffmann, S.N., Inactivation of calcium-binding protein genes induces 160 Hz oscillations in the cerebellar cortex of alert mice. J. Neurosci. 24 (2004), 434–441.
Cheron, G., Servais, L., Wagstaff, J., Dan, B., Fast cerebellar oscillation associated with ataxia in a mouse model of Angelman syndrome. Neuroscience 130 (2005), 631–637.
Cheron, G., Servais, L., Dan, B., Cerebellar network plasticity: from genes to fast oscillation. Neuroscience 153 (2008), 1–19.
Cheron, G., Sausbier, M., Sausbier, U., Neuhuber, W., Ruth, P., Dan, B., Servais, L., BK channels control cerebellar Purkinje and Golgi cell rhythmicity in vivo. PLoS ONE, 4, 2009, e7991.
Cheron, G., Dan, B., Márquez-Ruiz, J., Translational approach to behavioral learning: lessons from cerebellar plasticity. Neural Plast., 2013, 2013, 853654.
Dogan, C., De Antonio, M., Hamroun, D., Varet, H., Fabbro, M., Rougier, F., Amarof, K., Arne Bes, M.C., Bedat-Millet, A.L., Behin, A., et al. Gender as a modifying factor influencing myotonic dystrophy type 1 phenotype severity and mortality: a nationwide multiple databases cross-sectional observational study. PLoS ONE, 11, 2016, e0148264.
Gomes-Pereira, M., Foiry, L., Nicole, A., Huguet, A., Junien, C., Munnich, A., Gourdon, G., CTG trinucleotide repeat “big jumps”: large expansions, small mice. PLoS Genet., 3, 2007, e52.
Goodwin, M., Mohan, A., Batra, R., Lee, K.Y., Charizanis, K., Fernández Gómez, F.J., Eddarkaoui, S., Sergeant, N., Buée, L., Kimura, T., et al. MBNL sequestration by toxic RNAs and RNA misprocessing in the myotonic dystrophy brain. Cell Rep. 12 (2015), 1159–1168.
Hammarén, E., Kjellby-Wendt, G., Kowalski, J., Lindberg, C., Factors of importance for dynamic balance impairment and frequency of falls in individuals with myotonic dystrophy type 1—a cross-sectional study—including reference values of Timed Up & Go, 10m walk and step test. Neuromuscul. Disord. 24 (2014), 207–215.
Hernández-Hernández, O., Guiraud-Dogan, C., Sicot, G., Huguet, A., Luilier, S., Steidl, E., Saenger, S., Marciniak, E., Obriot, H., Chevarin, C., et al. Myotonic dystrophy CTG expansion affects synaptic vesicle proteins, neurotransmission and mouse behaviour. Brain 136 (2013), 957–970.
Hernández-Hernández, O., Sicot, G., Dinca, D.M., Huguet, A., Nicole, A., Buée, L., Munnich, A., Sergeant, N., Gourdon, G., Gomes-Pereira, M., Synaptic protein dysregulation in myotonic dystrophy type 1: disease neuropathogenesis beyond missplicing. Rare Dis., 1, 2013, e25553.
Higashimori, H., Morel, L., Huth, J., Lindemann, L., Dulla, C., Taylor, A., Freeman, M., Yang, Y., Astroglial FMRP-dependent translational down-regulation of mGluR5 underlies glutamate transporter GLT1 dysregulation in the fragile X mouse. Hum. Mol. Genet. 22 (2013), 2041–2054.
Huguet, A., Medja, F., Nicole, A., Vignaud, A., Guiraud-Dogan, C., Ferry, A., Decostre, V., Hogrel, J.Y., Metzger, F., Hoeflich, A., et al. Molecular, physiological, and motor performance defects in DMSXL mice carrying >1,000 CTG repeats from the human DM1 locus. PLoS Genet., 8, 2012, e1003043.
Kanadia, R.N., Johnstone, K.A., Mankodi, A., Lungu, C., Thornton, C.A., Esson, D., Timmers, A.M., Hauswirth, W.W., Swanson, M.S., A muscleblind knockout model for myotonic dystrophy. Science 302 (2003), 1978–1980.
Kanai, Y., Hediger, M.A., The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects. Pflugers Arch. 447 (2004), 469–479.
Kim, K., Lee, S.G., Kegelman, T.P., Su, Z.Z., Das, S.K., Dash, R., Dasgupta, S., Barral, P.M., Hedvat, M., Diaz, P., et al. Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics. J. Cell. Physiol. 226 (2011), 2484–2493.
Kiryk, A., Aida, T., Tanaka, K., Banerjee, P., Wilczynski, G.M., Meyza, K., Knapska, E., Filipkowski, R.K., Kaczmarek, L., Danysz, W., Behavioral characterization of GLT1 (+/−) mice as a model of mild glutamatergic hyperfunction. Neurotox. Res. 13 (2008), 19–30.
Kong, Q., Chang, L.C., Takahashi, K., Liu, Q., Schulte, D.A., Lai, L., Ibabao, B., Lin, Y., Stouffer, N., Das Mukhopadhyay, C., et al. Small-molecule activator of glutamate transporter EAAT2 translation provides neuroprotection. J. Clin. Invest. 124 (2014), 1255–1267.
Lin, C.L., Bristol, L.A., Jin, L., Dykes-Hoberg, M., Crawford, T., Clawson, L., Rothstein, J.D., Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 20 (1998), 589–602.
Minnerop, M., Weber, B., Schoene-Bake, J.C., Roeske, S., Mirbach, S., Anspach, C., Schneider-Gold, C., Betz, R.C., Helmstaedter, C., Tittgemeyer, M., et al. The brain in myotonic dystrophy 1 and 2: evidence for a predominant white matter disease. Brain 134 (2011), 3530–3546.
Mohan, A., Goodwin, M., Swanson, M.S., RNA-protein interactions in unstable microsatellite diseases. Brain Res. 1584 (2014), 3–14.
Panaite, P.A., Kuntzer, T., Gourdon, G., Lobrinus, J.A., Barakat-Walter, I., Functional and histopathological identification of the respiratory failure in a DMSXL transgenic mouse model of myotonic dystrophy. Dis. Model. Mech. 6 (2013), 622–631.
Regan, M.R., Huang, Y.H., Kim, Y.S., Dykes-Hoberg, M.I., Jin, L., Watkins, A.M., Bergles, D.E., Rothstein, J.D., Variations in promoter activity reveal a differential expression and physiology of glutamate transporters by glia in the developing and mature CNS. J. Neurosci. 27 (2007), 6607–6619.
Schneider-Gold, C., Bellenberg, B., Prehn, C., Krogias, C., Schneider, R., Klein, J., Gold, R., Lukas, C., Cortical and subcortical grey and white matter atrophy in myotonic dystrophies type 1 and 2 is associated with cognitive impairment, depression and daytime sleepiness. PLoS ONE, 10, 2015, e0130352.
Serra, L., Silvestri, G., Petrucci, A., Basile, B., Masciullo, M., Makovac, E., Torso, M., Spanò, B., Mastropasqua, C., Harrison, N.A., et al. Abnormal functional brain connectivity and personality traits in myotonic dystrophy type 1. JAMA Neurol. 71 (2014), 603–611.
Serra, L., Petrucci, A., Spanò, B., Torso, M., Olivito, G., Lispi, L., Costanzi-Porrini, S., Giulietti, G., Koch, G., Giacanelli, M., et al. How genetics affects the brain to produce higher-level dysfunctions in myotonic dystrophy type 1. Funct. Neurol. 30 (2015), 21–31.
Serra, L., Cercignani, M., Bruschini, M., Cipolotti, L., Mancini, M., Silvestri, G., Petrucci, A., Bucci, E., Antonini, G., Licchelli, L., et al. “I know that you know that I know”: neural substrates associated with social cognition deficits in DM1 patients. PLoS ONE, 11, 2016, e0156901.
Servais, L., Cheron, G., Purkinje cell rhythmicity and synchronicity during modulation of fast cerebellar oscillation. Neuroscience 134 (2005), 1247–1259.
Servais, L., Hourez, R., Bearzatto, B., Gall, D., Schiffmann, S.N., Cheron, G., Purkinje cell dysfunction and alteration of long-term synaptic plasticity in fetal alcohol syndrome. Proc. Natl. Acad. Sci. USA 104 (2007), 9858–9863.
Seznec, H., Lia-Baldini, A.S., Duros, C., Fouquet, C., Lacroix, C., Hofmann-Radvanyi, H., Junien, C., Gourdon, G., Transgenic mice carrying large human genomic sequences with expanded CTG repeat mimic closely the DM CTG repeat intergenerational and somatic instability. Hum. Mol. Genet. 9 (2000), 1185–1194.
Seznec, H., Agbulut, O., Sergeant, N., Savouret, C., Ghestem, A., Tabti, N., Willer, J.C., Ourth, L., Duros, C., Brisson, E., et al. Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities. Hum. Mol. Genet. 10 (2001), 2717–2726.
Sicot, G., Gomes-Pereira, M., RNA toxicity in human disease and animal models: from the uncovering of a new mechanism to the development of promising therapies. Biochim. Biophys. Acta 1832 (2013), 1390–1409.
Sicot, G., Gourdon, G., Gomes-Pereira, M., Myotonic dystrophy, when simple repeats reveal complex pathogenic entities: new findings and future challenges. Hum. Mol. Genet. 20:R2 (2011), R116–R123.
Sistiaga, A., Urreta, I., Jodar, M., Cobo, A.M., Emparanza, J., Otaegui, D., Poza, J.J., Merino, J.J., Imaz, H., Martí-Massó, J.F., López de Munain, A., Cognitive/personality pattern and triplet expansion size in adult myotonic dystrophy type 1 (DM1): CTG repeats, cognition and personality in DM1. Psychol. Med. 40 (2010), 487–495.
Takado, Y., Terajima, K., Ohkubo, M., Okamoto, K., Shimohata, T., Nishizawa, M., Igarashi, H., Nakada, T., Diffuse brain abnormalities in myotonic dystrophy type 1 detected by 3.0 T proton magnetic resonance spectroscopy. Eur. Neurol. 73 (2015), 247–256.
Tanaka, K., Watase, K., Manabe, T., Yamada, K., Watanabe, M., Takahashi, K., Iwama, H., Nishikawa, T., Ichihara, N., Kikuchi, T., et al. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 276 (1997), 1699–1702.
Theadom, A., Rodrigues, M., Roxburgh, R., Balalla, S., Higgins, C., Bhattacharjee, R., Jones, K., Krishnamurthi, R., Feigin, V., Prevalence of muscular dystrophies: a systematic literature review. Neuroepidemiology 43 (2014), 259–268.
Toth, A., Lovadi, E., Komoly, S., Schwarcz, A., Orsi, G., Perlaki, G., Bogner, P., Sebok, A., Kovacs, N., Pal, E., Janszky, J., Cortical involvement during myotonia in myotonic dystrophy: an fMRI study. Acta Neurol. Scand. 132 (2015), 65–72.
Udd, B., Krahe, R., The myotonic dystrophies: molecular, clinical, and therapeutic challenges. Lancet Neurol. 11 (2012), 891–905.
Voogd, J., Glickstein, M., The anatomy of the cerebellum. Trends Cogn. Sci. 2 (1998), 307–313.
Wang, E.T., Cody, N.A., Jog, S., Biancolella, M., Wang, T.T., Treacy, D.J., Luo, S., Schroth, G.P., Housman, D.E., Reddy, S., et al. Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins. Cell 150 (2012), 710–724.
Weber, Y.G., Roebling, R., Kassubek, J., Hoffmann, S., Rosenbohm, A., Wolf, M., Steinbach, P., Jurkat-Rott, K., Walter, H., Reske, S.N., et al. Comparative analysis of brain structure, metabolism, and cognition in myotonic dystrophy 1 and 2. Neurology 74 (2010), 1108–1117.
Wiles, C.M., Busse, M.E., Sampson, C.M., Rogers, M.T., Fenton-May, J., van Deursen, R., Falls and stumbles in myotonic dystrophy. J. Neurol. Neurosurg. Psychiatry 77 (2006), 393–396.
Wozniak, J.R., Mueller, B.A., Lim, K.O., Hemmy, L.S., Day, J.W., Tractography reveals diffuse white matter abnormalities in myotonic dystrophy type 1. J. Neurol. Sci. 341 (2014), 73–78.
